Evariant, the leading healthcare provider CRM platform, announced today it has raised a $42.3M Series C financing led by Goldman Sachs, with participation from Series A and B financing leads Health Enterprise Partners and Lightspeed Venture Partners. Jason Kreuziger from Goldman Sachs, has joined the Evariant Board of Directors.

'Our advances with big data and streaming analytics will yield significant market advantages to our customers. We are excited to leverage this additional investment to address core and new healthcare system requirements.'
Tweet this
Evariant offers an end-to-end healthcare CRM platform that helps health systems attract profitable patient volume and connect patients with providers around their care in new value-based healthcare delivery models. Healthcare systems are attracted to this seamless platform of software and analytics solutions that reduce the overall cost of care and deliver a better patient experience.

'We aim to invest in companies that are market leaders and solve major healthcare pain points by rethinking a traditional approach,' said Jason Kreuziger, a Vice President in the Merchant Banking Division of Goldman Sachs. 'With over 600 hospitals and six out of the top 10 health systems as customers, Evariant has clearly demonstrated to the healthcare provider market that they are the leaders and innovators to watch. The company has transformed many classic marketing and business development models by providing superior software products and customer experiences, leveraging sophisticated big data technology.'

With this latest round of funding, Evariant will focus on growing its engineering, services, and customer success teams, expanding its healthcare provider footprint. The company recently opened its fourth office in Austin, Texas that functions as the company's technology hub.

'It is no secret that healthcare systems are facing a variety of complex market challenges. These issues are not going to be solved by a collection of point solutions, but rather by an integrated platform that can scale and address the healthcare markets' analytics and CRM needs of today and tomorrow,' stated Evariant Chief Executive Officer William Moschella. 'Our advances with big data and streaming analytics will yield significant market advantages to our customers. We are excited to leverage this additional investment to address core and new healthcare system requirements.'

About Evariant
Evariant sees a future where healthcare organizations deliver precise, efficient care solutions not only inside an organization's walls, but also beyond. We make this a reality by continuously innovating a healthcare CRM platform - a platform based on a centralized healthcare data hub, analytics, and communications engine - capable of identifying, executing, and measuring all types of engagement initiatives. The result is greater visibility into opportunities, richer engagement with key constituents, and continuous measurement and improvement. Many of the leading healthcare institutions have selected our solutions to optimize their care strategies and related initiatives. Learn more at www.evariant.com.